Literature DB >> 34480806

Treatment options for leishmaniasis.

S Pradhan, R A Schwartz1, A Patil2, S Grabbe3,4, M Goldust4.   

Abstract

Leishmaniasis is broadly classified into three types: cutaneous, mucocutaneous and visceral. The visceral form is most dangerous and can result in death. Although leishmaniasis is an ancient disease, its treatment is still challenging. Several drugs, differing in their cost, toxicity, treatment duration and emergence of drug resistance, are used for different types of leishmaniasis. To overcome these limitations, the search for newer drugs and other treatments continues. In this article, we discuss conventional drugs, other treatments, including newer options such as immunotherapy and immunochemotherapy, and future prospects for leishmaniasis treatment.
© 2021 The Authors. Clinical and Experimental Dermatology published by John Wiley & Sons Ltd on behalf of British Association of Dermatologists.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34480806     DOI: 10.1111/ced.14919

Source DB:  PubMed          Journal:  Clin Exp Dermatol        ISSN: 0307-6938            Impact factor:   3.470


  2 in total

Review 1.  Covalent Reversible Inhibitors of Cysteine Proteases Containing the Nitrile Warhead: Recent Advancement in the Field of Viral and Parasitic Diseases.

Authors:  Simone Brogi; Roberta Ibba; Sara Rossi; Stefania Butini; Vincenzo Calderone; Sandra Gemma; Giuseppe Campiani
Journal:  Molecules       Date:  2022-04-15       Impact factor: 4.927

2.  Direct In Vitro Comparison of the Anti-Leishmanial Activity of Different Olive Oil Total Polyphenolic Fractions and Assessment of Their Combined Effects with Miltefosine.

Authors:  Georgia Gogou; Olga S Koutsoni; Panagiotis Stathopoulos; Leandros A Skaltsounis; Maria Halabalaki; Eleni Dotsika
Journal:  Molecules       Date:  2022-09-21       Impact factor: 4.927

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.